Bausch Health Companies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	10,156	9,518	8,663	8,025	8,328
Other Revenue	110	107	94	99	106
Revenue	10,266	9,625	8,757	8,124	8,434
Revenue Growth (YoY)	6.66%	9.91%	7.79%	-3.68%	5.07%
Cost of Revenue	3,013	2,782	2,559	2,364	2,394
Gross Profit	7,253	6,843	6,198	5,760	6,040
Selling, General & Admin	3,431	3,276	2,895	2,531	2,492
Research & Development	629	616	604	529	465
Amortization of Goodwill & Intangibles	1,001	1,077	1,077	1,215	1,375
Other Operating Expenses	-	-	1	1	-
Operating Expenses	5,061	4,969	4,577	4,276	4,332
Operating Income	2,192	1,874	1,621	1,484	1,708
Interest Expense	-1,604	-1,388	-1,328	-1,464	-1,426
Interest & Investment Income	48	33	26	14	7
Currency Exchange Gain (Loss)	-52	-47	-52	-8	7
EBT Excluding Unusual Items	584	472	267	26	296
Merger & Restructuring Charges	-86	-36	-95	-68	-73
Impairment of Goodwill	-145	-	-493	-824	-469
Gain (Loss) on Sale of Assets	6	10	3	5	2
Asset Writedown	-8	-29	-45	-10	-211
Legal Settlements	-61	-220	-	-9	-356
Other Unusual Items	191	-12	-80	752	-205
Pretax Income	367	167	-390	-129	-1,024
Income Tax Expense	247	239	221	83	-87
Earnings From Continuing Operations	120	-72	-611	-212	-937
Minority Interest in Earnings	37	26	19	-13	-11
Net Income	157	-46	-592	-225	-948
Net Income to Common	157	-46	-592	-225	-948
Shares Outstanding (Basic)	371	368	365	362	359
Shares Outstanding (Diluted)	375	368	365	362	359
Shares Change (YoY)	1.90%	0.85%	0.80%	0.86%	1.10%
EPS (Basic)	0.42	-0.13	-1.62	-0.62	-2.64
EPS (Diluted)	0.42	-0.13	-1.62	-0.62	-2.64
Free Cash Flow	1,003	1,260	817	-946	1,157
Free Cash Flow Per Share	2.67	3.42	2.24	-2.61	3.22
Gross Margin	70.65%	71.10%	70.78%	70.90%	71.61%
Operating Margin	21.35%	19.47%	18.51%	18.27%	20.25%
Profit Margin	1.53%	-0.48%	-6.76%	-2.77%	-11.24%
Free Cash Flow Margin	9.77%	13.09%	9.33%	-11.64%	13.72%
EBITDA	3,400	3,141	2,885	2,878	3,260
EBITDA Margin	33.12%	32.63%	32.95%	35.43%	38.65%
D&A For EBITDA	1,208	1,267	1,264	1,394	1,552
EBIT	2,192	1,874	1,621	1,484	1,708
EBIT Margin	21.35%	19.47%	18.51%	18.27%	20.25%
Effective Tax Rate	67.30%	143.11%	-	-	-
Revenue as Reported	10,266	9,625	8,757	8,124	8,434

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q